WallStreetZenWallStreetZen

NYSE: ECVT
ECOVYST INC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ECVT

Based on 4 analysts offering 12 month price targets for ECOVYST INC.
Min Forecast
$13.00+27.7%
Avg Forecast
$16.00+57.17%
Max Forecast
$18.00+76.82%

Should I buy or sell ECVT stock?

Based on 4 analysts offering ratings for ECOVYST INC.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ECVT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BWS Financial
Top 11%
90
BuyInitiates Coverage On$18.00+76.82%2022-03-23
Deutsche Bank
Top 3%
98
Strong BuyMaintains$13.00+27.70%2022-03-02
KeyBanc
Top 8%
93
Strong BuyMaintains$16.00+57.17%2022-02-28
Anonymous
Morgan Stanley
HoldMaintains$12.50+22.79%2021-08-16
BMO Capital
Top 27%
74
BuyInitiates Coverage On$17.00+66.99%2021-08-16

1 of 1

Forecast return on equity

Is ECVT forecast to generate an efficient return?
Company
N/A
Industry
21.38%
Market
30.86%

Forecast return on assets

Is ECVT forecast to generate an efficient return on assets?
Company
N/A
Industry
9.41%

ECVT earnings per share forecast

What is ECVT's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$0.61
Avg 2 year Forecast
$0.81
Avg 3 year Forecast
$1.09

ECVT revenue forecast

What is ECVT's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$790.6M+19.01%
Avg 2 year Forecast
$836.6M+25.94%
Avg 3 year Forecast
$918.5M+38.27%
ECVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ECVT revenue growth forecast

How is ECVT forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
10.92%
Industry
6.27%
Market
8.91%
ECVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ECVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ECVT vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
ECVT$10.18$16.00+57.17%Strong Buy
TSE$43.86$56.00+27.68%Buy
PRM$10.00$15.00+50.00%Strong Buy
OEC$18.46$21.00+13.76%Buy
GPRE$32.14$48.60+51.21%Buy
View Top Specialty Chemical Stocks

ECOVYST Stock Forecast FAQ

Is ECOVYST Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: ECVT) stock is to Strong Buy ECVT stock.

Out of 4 analysts, 2 (50%) are recommending ECVT as a Strong Buy, 2 (50%) are recommending ECVT as a Buy, 0 (0%) are recommending ECVT as a Hold, 0 (0%) are recommending ECVT as a Sell, and 0 (0%) are recommending ECVT as a Strong Sell.

What is ECVT's earnings growth forecast for 2022-2024?

(NYSE: ECVT) ECOVYST's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 28.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.71%.

ECOVYST's earnings in 2022 is -$39,439,000.On average, 5 Wall Street analysts forecast ECVT's earnings for 2022 to be $84,605,134, with the lowest ECVT earnings forecast at $65,187,562, and the highest ECVT earnings forecast at $115,118,461. On average, 5 Wall Street analysts forecast ECVT's earnings for 2023 to be $112,344,522, with the lowest ECVT earnings forecast at $76,283,318, and the highest ECVT earnings forecast at $156,727,543.

In 2024, ECVT is forecast to generate $151,179,666 in earnings, with the lowest earnings forecast at $151,179,666 and the highest earnings forecast at $151,179,666.

What is ECVT's revenue growth forecast for 2022-2024?

(NYSE: ECVT) ECOVYST's forecast annual revenue growth rate of 10.92% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 6.27%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.91%.

ECOVYST's revenue in 2022 is $664,291,000.On average, 5 Wall Street analysts forecast ECVT's revenue for 2022 to be $109,649,363,252, with the lowest ECVT revenue forecast at $101,637,118,365, and the highest ECVT revenue forecast at $114,492,937,826. On average, 5 Wall Street analysts forecast ECVT's revenue for 2023 to be $116,037,744,355, with the lowest ECVT revenue forecast at $107,226,605,087, and the highest ECVT revenue forecast at $121,529,033,643.

In 2024, ECVT is forecast to generate $127,398,688,186 in revenue, with the lowest revenue forecast at $125,798,125,487 and the highest revenue forecast at $128,999,250,885.

What is ECVT's forecast return on assets (ROA) for 2022-2025?

(NYSE: ECVT) forecast ROA is N/A, which is lower than the forecast US Specialty Chemicals industry average of 9.41%.

What is ECVT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ECVT price target, the average ECVT price target is $16.00, with the highest ECVT stock price forecast at $18.00 and the lowest ECVT stock price forecast at $13.00.

On average, Wall Street analysts predict that ECOVYST's share price could reach $16.00 by Mar 23, 2023. The average ECOVYST stock price prediction forecasts a potential upside of 57.17% from the current ECVT share price of $10.18.

What is ECVT's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: ECVT) ECOVYST's current Earnings Per Share (EPS) is -$0.28. On average, analysts forecast that ECVT's EPS will be $0.61 for 2022, with the lowest EPS forecast at $0.47, and the highest EPS forecast at $0.83. On average, analysts forecast that ECVT's EPS will be $0.81 for 2023, with the lowest EPS forecast at $0.55, and the highest EPS forecast at $1.13. In 2024, ECVT's EPS is forecast to hit $1.09 (min: $1.09, max: $1.09).

What is ECVT's forecast return on equity (ROE) for 2022-2025?

(NYSE: ECVT) forecast ROE is N/A, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.